345 related articles for article (PubMed ID: 32121563)
1. Influenza A Virus Antibodies with Antibody-Dependent Cellular Cytotoxicity Function.
Gao R; Sheng Z; Sreenivasan CC; Wang D; Li F
Viruses; 2020 Mar; 12(3):. PubMed ID: 32121563
[TBL] [Abstract][Full Text] [Related]
2. Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.
He W; Tan GS; Mullarkey CE; Lee AJ; Lam MM; Krammer F; Henry C; Wilson PC; Ashkar AA; Palese P; Miller MS
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11931-11936. PubMed ID: 27698132
[TBL] [Abstract][Full Text] [Related]
3. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
[TBL] [Abstract][Full Text] [Related]
4. Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine.
Boudreau CM; Alter G
Front Immunol; 2019; 10():440. PubMed ID: 30949165
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Administration of Broadly Neutralizing FI6 Antibody Reveals Lack of Interaction Between Human IgG1 and Pig Fc Receptors.
Morgan SB; Holzer B; Hemmink JD; Salguero FJ; Schwartz JC; Agatic G; Cameroni E; Guarino B; Porter E; Rijal P; Townsend A; Charleston B; Corti D; Tchilian E
Front Immunol; 2018; 9():865. PubMed ID: 29740451
[TBL] [Abstract][Full Text] [Related]
6. Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice.
Asthagiri Arunkumar G; Ioannou A; Wohlbold TJ; Meade P; Aslam S; Amanat F; Ayllon J; García-Sastre A; Krammer F
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626682
[TBL] [Abstract][Full Text] [Related]
7. Different mechanisms of the protection against influenza A infection mediated by broadly reactive HA2-specific antibodies.
Tomčíková K; Varečková E
Acta Virol; 2019; 63(4):347-365. PubMed ID: 31802678
[TBL] [Abstract][Full Text] [Related]
8. Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay.
Chromikova V; Tan J; Aslam S; Rajabhathor A; Bermudez-Gonzalez M; Ayllon J; Simon V; García-Sastre A; Salaun B; Nachbagauer R; Krammer F
Vaccine; 2020 Feb; 38(8):1953-1961. PubMed ID: 31959425
[TBL] [Abstract][Full Text] [Related]
9. Potential Role of Nonneutralizing IgA Antibodies in Cross-Protective Immunity against Influenza A Viruses of Multiple Hemagglutinin Subtypes.
Okuya K; Yoshida R; Manzoor R; Saito S; Suzuki T; Sasaki M; Saito T; Kida Y; Mori-Kajihara A; Kondoh T; Sato M; Kajihara M; Miyamoto H; Ichii O; Higashi H; Takada A
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269119
[TBL] [Abstract][Full Text] [Related]
10. Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model.
Ermler ME; Kirkpatrick E; Sun W; Hai R; Amanat F; Chromikova V; Palese P; Krammer F
J Virol; 2017 Jun; 91(12):. PubMed ID: 28356526
[TBL] [Abstract][Full Text] [Related]
11. Contribution of Fc-dependent cell-mediated activity of a vestigial esterase-targeting antibody against H5N6 virus infection.
Zheng Z; Teo SHC; Arularasu SC; Liu Z; Mohd-Ismail NK; Mok CK; Ong CB; Chu JJ; Tan YJ
Emerg Microbes Infect; 2020; 9(1):95-110. PubMed ID: 31906790
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with 2014-15 Seasonal Inactivated Influenza Vaccine Elicits Cross-Reactive Anti-HA Antibodies with Strong ADCC Against Antigenically Drifted Circulating H3N2 Virus in Humans.
Zhong W; Gross FL; Holiday C; Jefferson SN; Bai Y; Liu F; Katz JM; Levine MZ
Viral Immunol; 2016 May; 29(4):259-62. PubMed ID: 26950058
[TBL] [Abstract][Full Text] [Related]
13. The protective potential of Fc-mediated antibody functions against influenza virus and other viral pathogens.
Vanderven HA; Kent SJ
Immunol Cell Biol; 2020 Apr; 98(4):253-263. PubMed ID: 31914207
[TBL] [Abstract][Full Text] [Related]
14. Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine.
Jegaskanda S; Reading PC; Kent SJ
J Immunol; 2014 Jul; 193(2):469-75. PubMed ID: 24994909
[TBL] [Abstract][Full Text] [Related]
15. Broadly neutralizing anti-influenza virus antibodies: enhancement of neutralizing potency in polyclonal mixtures and IgA backbones.
He W; Mullarkey CE; Duty JA; Moran TM; Palese P; Miller MS
J Virol; 2015 Apr; 89(7):3610-8. PubMed ID: 25589655
[TBL] [Abstract][Full Text] [Related]
16. Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes.
Liao HY; Wang SC; Ko YA; Lin KI; Ma C; Cheng TR; Wong CH
Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17757-17763. PubMed ID: 32669430
[TBL] [Abstract][Full Text] [Related]
17. Divergent Requirement of Fc-Fcγ Receptor Interactions for
Wang S; Ren H; Jiang W; Chen H; Hu H; Chen Z; Zhou P
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331095
[TBL] [Abstract][Full Text] [Related]
18. Neutralizing Antibody Responses to Homologous and Heterologous H1 and H3 Influenza A Strains After Vaccination With Inactivated Trivalent Influenza Vaccine Vary With Age and Prior-year Vaccination.
Wang W; Chen Q; Ford-Siltz LA; Katzelnick LC; Parra GI; Song HS; Vassell R; Weiss CD
Clin Infect Dis; 2019 May; 68(12):2067-2078. PubMed ID: 30256912
[TBL] [Abstract][Full Text] [Related]
19. Measuring influenza hemagglutinin (HA) stem-specific antibody-dependent cellular cytotoxicity (ADCC) in human sera using novel stabilized stem nanoparticle probes.
Smatti MK; Nasrallah GK; Al Thani AA; Yassine HM
Vaccine; 2020 Jan; 38(4):815-821. PubMed ID: 31735504
[TBL] [Abstract][Full Text] [Related]
20. A Host-Restricted Self-Attenuated Influenza Virus Provides Broad Pan-Influenza A Protection in a Mouse Model.
Kim M; Cheong Y; Lee J; Lim J; Byun S; Jang YH; Seong BL
Front Immunol; 2021; 12():779223. PubMed ID: 34925355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
